Almeda Ventures Limited Partnership (TLV:AMDA)
Israel · Delayed Price · Currency is ILS · Price in ILA 268.50
+1.90 (0.71%)
At close: Sep 2, 2026
TLV:AMDA Revenue
Almeda Ventures Limited Partnership had revenue of $3.45M USD in the half year ending December 31, 2025, with 19,066.67% growth. This brings the company's revenue in the last twelve months to $10.74M. In the year 2025, Almeda Ventures Limited Partnership had annual revenue of $2.47M.
Revenue (ttm)
$10.74M
Revenue Growth
n/a
P/S Ratio
1.63
Revenue / Employee
n/a
Employees
n/a
Market Cap
52.08M ILS
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.47M | 5.48M | - |
| Dec 31, 2024 | -3.02M | -2.72M | - |
| Dec 31, 2023 | -292.00K | -1.20M | - |
| Dec 31, 2022 | 907.00K | -690.00K | -43.21% |
| Dec 31, 2021 | 1.60M | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 51.58B |
| Danel (Adir Yeoshua) | 2.98B |
| Amal Holdings A.D. | 2.18B |
| Nissan Medical Industries | 607.36M |
| BrainsWay | 180.82M |
| Together Pharma | 99.94M |
| BioLineRx | 4.15M |
| Epitomee Medical | 2.32M |